2014 - 2016 Constraction of basis of glioblastoma treatment targeting for GSK3beta
2012 - 2014 Basic base constraction of malignant glioma therapy targeting for GSK3beta
Show all
Papers (61):
Yasuo Sugita, Takuya Furuta, Kenji Takahashi, Koichi Higaki, Yuichi Murakami, Michihiko Kuwano, Mayumi Ono, Hideyuki Abe, Jun Akiba, Motohiro Morioka. Elevated expression of N-myc downstream regulated gene 1 protein in glioblastomas reflects tumor angiogenesis and poor patient prognosis. Neuropathology : official journal of the Japanese Society of Neuropathology. 2024
Mayuko Moritsubo, Takuya Furuta, Junko Miyoshi, Satoru Komaki, Kiyohiko Sakata, Hiroaki Miyoshi, Motohiro Morioka, Koichi Ohshima, Yasuo Sugita. Increased expression of leucine-rich α-2 glycoprotein 1 as a predictive biomarker of favorable progression-free survival in meningioma. Neuropathology : official journal of the Japanese Society of Neuropathology. 2024. 44. 2. 96-103
Mayuko Moritsubo, Takuya Furuta, Tetsuya Negoto, Hideo Nakamura, Yusuke Uchiyama, Motohiro Morioka, Koichi Oshima, Yasuo Sugita. A case of a pilocytic astrocytoma with histological features of anaplasia and unprecedent genetic alterations. Neuropathology : official journal of the Japanese Society of Neuropathology. 2024. 44. 2. 161-166
Tatsuzo Mishina, Hiroaki Miyoshi, Mai Takeuchi, Kohta Miyawaki, Kazutaka Nakashima, Kyohei Yamada, Mayuko Moritsubo, Kanako Inoue-Mitsuyama, Yasumasa Shimasaki, Teppei Imamoto, et al. Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphoma. Pathology, research and practice. 2024. 254. 155117-155117
Yasumasa Shimasaki, Hiroaki Miyoshi, Keisuke Kawamoto, Noriaki Yoshida, Tatsuzo Mishina, Kazutaka Nakashima, Teppei Imamoto, Takeshi Sugio, Eriko Yanagida, Takeharu Kato, et al. Clinicopathological comparison between PTCL-TBX21 and PTCL-GATA3 in Japanese patients. Cancer medicine. 2024